Turning health into a comparable measure
A quality-adjusted life year, or QALY, combines two things: how long someone lives and how good their health is during that time. Planners assign health states a value on a scale where full health is typically treated as 1 and death as 0; some states may be valued below 0. Time in each state is multiplied by its value, then added together.
That makes different treatment outcomes easier to compare. A treatment that adds years while easing severe symptoms can produce more QALYs than one that adds the same amount of time without improving how the person feels or functions. A treatment that improves daily life without extending it can also add QALYs.
The budget question behind the calculation
When a health system compares a treatment’s cost with the QALYs it is expected to produce, it can estimate the cost per QALY gained. The figure does not tell planners what a life is worth. It helps them ask what health improvement they could obtain for the money—and what other care might go unfunded if they spend it here.
This is especially useful when a decision affects many people or competes with other demands on a limited budget. But the calculation is not a verdict. Estimates depend on evidence about treatment effects, costs, and how people value different health states. Those values may not capture every aspect of living with a condition.
What the measure can leave out
A single score can also obscure who benefits. The same total QALY gain might come from a large improvement for one person or smaller gains for many; the arithmetic alone does not say which distribution is fair. Decision-makers may weigh severity, access, and other ethical concerns alongside the estimate.
The practical implication is that a QALY makes tradeoffs visible, not automatic: it gives planners a common yardstick, while leaving them responsible for deciding what that yardstick should—and should not—decide.
